Cyclophosphamide, Mitoxantrone, Fluorouracil versus Conventional CMF as Adjuvant Treatment in Node-Positive Breast Cancer Patients

Fountzilas, G; Polichronis, A; Katsohis, K; Gennatas, K; Toussis, D; Skarlos, D; Kosmidis, P; Vassilaros, S; Semoglou, C; Giannakakis, T; Fahantidis, E; Klouvas, G; Tsavaris, N; Konstantaras, C; Makrantonakis, P; Kolotas, C; Zamboglou, N; Tsiliakos, S; Hainoglou, D; Mylonakis, N; Pavlidis, N

dc.contributor.author	Fountzilas, G	en
dc.contributor.author	Polichronis, A	en
dc.contributor.author	Katsohis, K	en
dc.contributor.author	Gennatas, K	en
dc.contributor.author	Toussis, D	en
dc.contributor.author	Skarlos, D	en
dc.contributor.author	Kosmidis, P	en
dc.contributor.author	Vassilaros, S	en
dc.contributor.author	Semoglou, C	en
dc.contributor.author	Giannakakis, T	en
dc.contributor.author	Fahantidis, E	en
dc.contributor.author	Klouvas, G	en
dc.contributor.author	Tsavaris, N	en
dc.contributor.author	Konstantaras, C	en
dc.contributor.author	Makrantonakis, P	en
dc.contributor.author	Kolotas, C	en
dc.contributor.author	Zamboglou, N	en
dc.contributor.author	Tsiliakos, S	en
dc.contributor.author	Hainoglou, D	en
dc.contributor.author	Mylonakis, N	en
dc.contributor.author	Pavlidis, N	en
dc.date.accessioned	2014-03-01T01:44:17Z
dc.date.available	2014-03-01T01:44:17Z
dc.date.issued	1996	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/24323
dc.subject	Breast Cancer	en
dc.title	Cyclophosphamide, Mitoxantrone, Fluorouracil versus Conventional CMF as Adjuvant Treatment in Node-Positive Breast Cancer Patients	en
heal.type	journalArticle	en
heal.identifier.primary	10.1159/000227550	en
heal.identifier.secondary	http://dx.doi.org/10.1159/000227550	en
heal.publicationDate	1996	en
heal.journalName	Oncology	en
dc.identifier.doi	10.1159/000227550	en